Evidence map›Paper›PMID 40305305›Full record

SynthesisBiomolecules2025

Etiologies of Multidrug-Resistant Epilepsy in Latin America: A Comprehensive Review of Structural, Genetic, Metabolic, Inflammatory, and Infectious Origins: A Systematic Review.

Mario S Hinojosa-Figueroa, Mishell Cruz-Caraguay, Alejandro Torres Pasquel, Vanesa Puga Rosero, Camila Belen Eguiguren Chavez, Jose A Rodas, Jose E Leon-Rojas

Abstract readSystematic Review
In one paragraph

Synthesis in Biomolecules, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mario S Hinojosa-FigueroaNeurALL Research Group, Quito 170157, Ecuador.
Mishell Cruz-CaraguayNeurALL Research Group, Quito 170157, Ecuador.ORCID 0000-0003-1501-4053
Alejandro Torres PasquelNeurALL Research Group, Quito 170157, Ecuador.
Vanesa Puga RoseroNeurALL Research Group, Quito 170157, Ecuador.
Camila Belen Eguiguren ChavezNeurALL Research Group, Quito 170157, Ecuador.ORCID 0009-0000-4687-2611
Jose A RodasSchool of Psychology, University College Dublin, D04 C1P1 Dublin, Ireland.ORCID 0000-0001-8217-0238
Jose E Leon-RojasEscuela de Medicina, Universidad de las Américas, Quito 170124, Ecuador.ORCID 0000-0002-8130-6460

Funding

Universidad de las Américas MED.JLR.23.01
6 · The paper itself

Abstract

Epilepsy is a prevalent neurological disorder that affects millions worldwide, with a significant portion of individuals experiencing drug-resistant forms of the condition. In Latin America, the challenge of identifying the underlying causes of multidrug-resistant epilepsy (MDRE) is particularly pressing. (1) Background: This systematic review aims to highlight the critical importance of understanding the etiology of MDRE in Latin America. (2) Methods: A systematic review of Medline (PubMed), Scopus, and Web of Science was conducted following the PRISMA methodology; articles were selected if they included information on the etiology of MDRE in Latin-American participants, and the NHLBI tool was used to assess bias. (3) Results: A total of 37 published articles were finally included in the review. The most frequently documented cause of drug-resistant epilepsy was structural, affecting 725 patients, with hippocampal atrophy and sclerosis predominantly involving both the right and left lobes. The second most common cause was genetic, identified in 362 individuals who exhibited polymorphisms in genes such as

Indexed as

Drug Resistant EpilepsyHumansInflammationLatin AmericacausesetiologyLatin Americamultidrug-resistant epilepsyprevalence

Identifiers

PMID40305305
PMCPMC12025188

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.